Lung cancer surgery: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(18 intermediate revisions by 7 users not shown)
Line 2: Line 2:
{{Lung cancer}}
{{Lung cancer}}


{{CMG}}; '''Associate Editor(s)-In-Chief:''' Kim-Son H. Nguyen, M.D., M.P.A., Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA, {{CZ}}
{{CMG}}; {{AE}} {{SH}}


==Overview==
==Overview==
'''Lung cancer surgery''' describes the use of [[surgery|surgical operations]] in the treatment of [[lung cancer]]. It involves the surgical excision of cancer tissue from the lung. It is used mainly in [[non-small cell lung cancer]] with the intention of curing the patient.
Lung cancer [[surgery]] involves the [[Excision|surgical excision]] of the [[Cancer|cancerous]] [[Tissue (biology)|tissue]]. It is used mainly in [[non-small cell lung cancer]] with the intention of [[Cure|curing]] the [[patient]].
 
==Pre-operative Evaluation==
 
If investigations confirm lung cancer, CT scan and often [[positron emission tomography]] (PET) are used to determine whether the disease is localised and amenable to surgery or whether it has spread to the point where it cannot be cured surgically.
 
[[Blood test]]s and [[spirometry]] (lung function testing) are also necessary to assess whether the patient is well enough to be operated on. If spirometry reveals poor respiratory reserve (often due to [[chronic obstructive pulmonary disease]]), surgery may be contraindicated.
 
Surgery itself has an operative death rate of about 4.4%, depending on the patient's lung function and other risk factors.<ref name="Strand">{{cite journal | last =Strand | first =TE | coauthors =Rostad H, Damhuis RA, Norstein J  | title =Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude | journal =Thorax | publisher =BMJ Publishing Group Ltd. | date =Jun 2007 | pmid =17573442 }}</ref> Surgery is usually only an option in non-small cell lung carcinoma limited to one lung, up to stage IIIA. This is assessed with medical imaging ([[computed tomography]], [[positron emission tomography]]). A sufficient pre-operative respiratory reserve must be present to allow adequate lung function after the tissue is removed.
 
=== Pulmonary reserve ===
Pulmonary reserve is measured by [[spirometry]]. The minimum [[forced vital capacity]] (FVC) for [[pneumonectomy]] in men is 2 [[liter]]s. The minimum for lobectomy is 1.5 liters. In women, the minimum FVC values for pneumonectomy and lobectomy are 1.75 liters and 1.25 liters respectively.<ref name="Schirren">{{cite journal | last =Schirren | first =J | authorlink = | coauthors =Krysa S, Trainer S et al.  | title =Surgical treatment and results. Carcinoma of the lung | journal =The European Respiratory Monograph | volume =1 | issue =1 | pages =212-240 | publisher = | date =1995 | url = | doi = | id = | accessdate = }}</ref>


==Surgery==
==Surgery==
Procedures include [[wedge resection (lung)|wedge resection]] (removal of part of a lobe), [[lobectomy (lung)|lobectomy]] (one lobe), bilobectomy (two lobes) or [[pneumonectomy]] (whole lung). In patients with adequate respiratory reserve, lobectomy is the preferred option, as this minimizes the chance of local recurrence. If the patient does not have enough functional lung for this, wedge resection may be performed.<ref name="El-Sherif">{{cite journal | last =El-Sherif | first =A | coauthors =Gooding WE, Santos R et al. | title =Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis | journal =Annals of Thoracic Surgery | volume =82 | issue =2 | pages =408–415 | date =Aug 2006 | pmid =16863738 }}</ref> Radioactive [[iodine]] [[brachytherapy]] at the margins of wedge excision may reduce recurrence to that of lobectomy.<ref name="Fernando">{{cite journal | last =Fernando | first =HC | coauthors =Santos RS, Benfield JR et al. | title =Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer | journal =Journal of Thoracic and Cardiovascular Surgery |volume =129 | issue =2 | pages =261–267 | date =Feb 2005 | pmid =15678034 }}</ref>
*[[Surgery]] is the best treatment option for [[Patient|patients]] with [[Resection|resectable]] [[Tumor|tumors]].
 
*The feasibility of [[surgery]] depends on the [[Cancer staging|stage]] of lung cancer at the time of [[diagnosis]].
Also, many times during lung cancer surgery, the doctor will remove some of the [[lymph nodes]] to test for cancer. If the lymph nodes test positive for cancer then that is indicative of the disease spreading beyond the lung. There will most likely be subsequent treatments to help eliminate the remaining cancer.
*The [[Surgery|surgical]] [[Procedure|procedures]] for lung cancer include:<ref name="El-Sherif">{{cite journal | last =El-Sherif | first =A | coauthors =Gooding WE, Santos R et al. | title =Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis | journal =Annals of Thoracic Surgery | volume =82 | issue =2 | pages =408–415 | date =Aug 2006 | pmid =16863738 }}</ref><ref name="Fernando">{{cite journal | last =Fernando | first =HC | coauthors =Santos RS, Benfield JR et al. | title =Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer | journal =Journal of Thoracic and Cardiovascular Surgery |volume =129 | issue =2 | pages =261–267 | date =Feb 2005 | pmid =15678034 }}</ref>
 
**[[Wedge resection (lung)|Wedge resection]] (removal of part of a [[Lobe (anatomy)|lobe]])
=== Patient selection ===
***[[Wedge resection (lung)|Wedge resection]] is performed in [[Patient|patients]] who do not have adequate [[respiratory]] reserve.
 
***[[Iodine-131|Radioactive iodine]] [[brachytherapy]] at the margins of [[Wedge resection (lung)|wedge resection]] may reduce the recurrence rate to that of [[lobectomy]].
Not all patients are suitable for operation. The [[cancer staging|stage]], location and cell type are important limiting factors. In addition, patients who are very ill with a poor [[performance status]] or who have inadequate pulmonary reserve would be unlikely to survive. Even with careful selection, the overall operative death rate is about 4.4%.<ref name="Strand">{{cite journal | last =Strand | first =TE | coauthors =Rostad H, Damhuis RA, Norstein J  | title =Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude | journal =Thorax | publisher =BMJ Publishing Group Ltd. | date =Jun 2007 | pmid =17573442 }}</ref>
**[[Lobectomy (lung)|Lobectomy]] (removal of a single [[Lobe (anatomy)|lobe]] of the [[lung]])
***[[Lobectomy]] is the preferred option for [[Patient|patients]] with adequate [[respiratory]] reserve because it reduces the chances of local recurrence.
**Bi-[[lobectomy]] (removal of two [[Lobe (anatomy)|lobes]])
**[[Pneumonectomy]] (removal of an entire [[lung]])
**[[Sleeve resection]]


=== Patient Selection ===
*The overall operative [[mortality rate]] even after careful [[patient]] selection is about 4.4%.<ref name="Strand">{{cite journal | last =Strand | first =TE | coauthors =Rostad H, Damhuis RA, Norstein J  | title =Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude | journal =Thorax | publisher =BMJ Publishing Group Ltd. | date =Jun 2007 | pmid =17573442 }}</ref>
*The [[patient]] selection for lung cancer depends on:
**The [[cancer staging|stage]]
**Location and [[Cell (biology)|cell]] type
**[[Lung|Pulmonary]] reserve
**[[Heart|Cardiac]] evaluation
==== Stage ====
==== Stage ====
*In non-small cell lung cancer, the following [[Cancer staging|stages]] are suitable for [[surgical resection]]:<ref name="Mountain">{{cite journal | last =Mountain | first =CF | authorlink = | coauthors = | title =Revisions in the international system for staging lung cancer | journal =Chest | volume =111 | issue = | pages =1710-1717  | publisher =American College of Chest Physicians  | date =1997 | url =http://www.chestjournal.org/cgi/reprint/111/6/1710 | doi = | id = | accessdate =  }}</ref>
**Stage IA
**Stage IB
**Stage IIA
**Stage IIB
*[[Surgery|Surgical intervention]] is not recommended for the management of lung cancer [[Patient|patients]] with the following [[Cancer staging|stages]]:
**Stage IIIA
**Stage IIIB
**Stage IV


"[[Cancer staging|Stage]]" refers to the degree of spread of the cancer.
For more information on staging, please visit ''[[non-small cell lung cancer staging]].''
 
''See [[non-small cell lung cancer staging]]''
 
In non-small cell lung cancer, stages IA, IB, IIA, and IIB are suitable for surgical resection.<ref name="Mountain">{{cite journal | last =Mountain | first =CF | authorlink = | coauthors = | title =Revisions in the international system for staging lung cancer | journal =Chest | volume =111 | issue = | pages =1710-1717  | publisher =American College of Chest Physicians  | date =1997 | url =http://www.chestjournal.org/cgi/reprint/111/6/1710 | doi = | id = | accessdate =  }}</ref> Stages IIIA, IIIB, and IV tend to involve the spreading out of the cancer.  In that case [[chemotherapy]] or radiation is usually deemed the appropriate action to take because surgery will not adequately solve the diseased lungs.
 
=== Types of surgery ===


* [[Lobectomy (lung)|Lobectomy]] (removal of a lobe of the lung)
=== Pulmonary Reserve ===
* [[Pneumonectomy]] (removal of an entire lung)
*A sufficient preoperative [[Lung|pulmonary]] reserve must be present to allow adequate [[lung]] function after the [[tissue]] is removed.
* [[Wedge resection (lung)|Wedge resection]]
*[[Lung|Pulmonary]] reserve is measured by [[spirometry]].
* [[Sleeve resection]]
*The preoperative [[Physiological|physiologic]] evaluation established by the [[American College of Chest Physicians]] for [[Patient|patients]] with lung cancer for [[surgical resection]] include:<ref name="pmid23649437">{{cite journal| author=Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ| title=Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. | journal=Chest | year= 2013 | volume= 143 | issue= 5 Suppl | pages= e166S-90S | pmid=23649437 | doi=10.1378/chest.12-2395 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23649437  }} </ref><ref name="Schirren">{{cite journal | last =Schirren | first =J | authorlink = | coauthors =Krysa S, Trainer S et al.  | title =Surgical treatment and results. Carcinoma of the lung | journal =The European Respiratory Monograph | volume =1 | issue =1 | pages =212-240 | publisher = | date =1995 | url = | doi = | id = | accessdate = }}</ref>
**[[Spirometry]]
** Measurement of [[FEV1]] and [[DLCO|carbon monoxide diffusion capacity (DLCO)]].
***The minimum [[forced vital capacity|forced vital capacity (FVC)]] for [[pneumonectomy]] in men is 2 [[liter]]s.
***The minimum [[forced vital capacity|forced vital capacity (FVC)]] for [[lobectomy]] is 1.5 liters.
*** In [[Female|women]], the minimum [[FVC]] values for [[pneumonectomy]] and [[lobectomy]] are 1.75 liters and 1.25 liters, respectively.
*[[Surgery]] is contraindicated if [[spirometry]] reveals poor [[respiratory]] reserve which is often due to underlying [[chronic obstructive pulmonary disease|chronic obstructive pulmonary disease (COPD)]].


==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Lung cancer]]
[[Category:Lung cancer]]
[[Category:Oncology]]
 
{{Tumors}}
{{Tumors}}


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Pulmonology]]
[[Category:Surgery]]

Latest revision as of 20:47, 8 July 2019

Lung cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lung cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lung cancer surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lung cancer surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lung cancer surgery

CDC on Lung cancer surgery

Lung cancer surgery in the news

Blogs on Lung cancer surgery

Directions to Hospitals Treating Lung cancer

Risk calculators and risk factors for Lung cancer surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]

Overview

Lung cancer surgery involves the surgical excision of the cancerous tissue. It is used mainly in non-small cell lung cancer with the intention of curing the patient.

Surgery

Patient Selection

Stage

For more information on staging, please visit non-small cell lung cancer staging.

Pulmonary Reserve

References

  1. ↑ El-Sherif, A (Aug 2006). "Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis". Annals of Thoracic Surgery. 82 (2): 408–415. PMID 16863738. Unknown parameter |coauthors= ignored (help)
  2. ↑ Fernando, HC (Feb 2005). "Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer". Journal of Thoracic and Cardiovascular Surgery. 129 (2): 261–267. PMID 15678034. Unknown parameter |coauthors= ignored (help)
  3. ↑ Strand, TE (Jun 2007). "Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude". Thorax. BMJ Publishing Group Ltd. PMID 17573442. Unknown parameter |coauthors= ignored (help)
  4. ↑ Mountain, CF (1997). "Revisions in the international system for staging lung cancer". Chest. American College of Chest Physicians. 111: 1710–1717.
  5. ↑ Brunelli A, Kim AW, Berger KI, Addrizzo-Harris DJ (2013). "Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines". Chest. 143 (5 Suppl): e166S–90S. doi:10.1378/chest.12-2395. PMID 23649437.
  6. ↑ Schirren, J (1995). "Surgical treatment and results. Carcinoma of the lung". The European Respiratory Monograph. 1 (1): 212–240. Unknown parameter |coauthors= ignored (help)

Template:Tumors


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Lung_cancer_surgery&oldid=1575256"